Petrus Trust Company LTA Makes New Investment in Health Catalyst, Inc. $HCAT

Petrus Trust Company LTA purchased a new position in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 95,386 shares of the company's stock, valued at approximately $432,000. Petrus Trust Company LTA owned approximately 0.14% of Health Catalyst as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Health Catalyst by 7.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 36,047 shares of the company's stock worth $163,000 after acquiring an additional 2,624 shares in the last quarter. AQR Capital Management LLC grew its holdings in Health Catalyst by 816.8% during the 1st quarter. AQR Capital Management LLC now owns 168,344 shares of the company's stock worth $763,000 after acquiring an additional 149,981 shares in the last quarter. Adage Capital Partners GP L.L.C. grew its holdings in Health Catalyst by 114.4% during the 1st quarter. Adage Capital Partners GP L.L.C. now owns 159,280 shares of the company's stock worth $722,000 after acquiring an additional 85,000 shares in the last quarter. First Light Asset Management LLC grew its holdings in Health Catalyst by 99.1% during the 1st quarter. First Light Asset Management LLC now owns 10,436,807 shares of the company's stock worth $47,279,000 after acquiring an additional 5,195,686 shares in the last quarter. Finally, Cubist Systematic Strategies LLC grew its holdings in Health Catalyst by 19.3% during the 1st quarter. Cubist Systematic Strategies LLC now owns 164,250 shares of the company's stock worth $744,000 after acquiring an additional 26,580 shares in the last quarter. Institutional investors and hedge funds own 85.00% of the company's stock.

Analyst Ratings Changes

Several research firms have commented on HCAT. Evercore ISI boosted their price target on shares of Health Catalyst from $3.00 to $4.00 and gave the stock an "in-line" rating in a report on Thursday, August 28th. Cantor Fitzgerald restated a "neutral" rating and issued a $4.00 target price (down previously from $9.00) on shares of Health Catalyst in a report on Friday, August 8th. Citigroup cut shares of Health Catalyst from a "buy" rating to a "neutral" rating and lowered their target price for the company from $6.50 to $3.50 in a report on Friday, August 8th. BTIG Research restated a "neutral" rating on shares of Health Catalyst in a report on Friday, September 5th. Finally, Piper Sandler cut shares of Health Catalyst from an "overweight" rating to a "neutral" rating and lowered their target price for the company from $8.00 to $4.00 in a report on Wednesday, August 27th. Three investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $4.73.

Health Catalyst Stock Performance

HCAT stock traded down $0.11 on Friday, hitting $3.13. The company's stock had a trading volume of 776,691 shares, compared to its average volume of 853,648. The firm has a 50 day moving average of $3.51 and a two-hundred day moving average of $3.86. Health Catalyst, Inc. has a 1 year low of $2.52 and a 1 year high of $9.24. The stock has a market cap of $220.27 million, a price-to-earnings ratio of -2.07 and a beta of 1.53. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.44.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.